Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA606807
Max Phase: Preclinical
Molecular Formula: C21H20ClN5O3
Molecular Weight: 425.88
Molecule Type: Small molecule
Associated Items:
ID: ALA606807
Max Phase: Preclinical
Molecular Formula: C21H20ClN5O3
Molecular Weight: 425.88
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N/N=C/c2ccc(Cl)cc2)cc1
Standard InChI: InChI=1S/C21H20ClN5O3/c1-30-18-8-4-15(5-9-18)20(28)26-19(10-17-12-23-13-24-17)21(29)27-25-11-14-2-6-16(22)7-3-14/h2-9,11-13,19H,10H2,1H3,(H,23,24)(H,26,28)(H,27,29)/b25-11+/t19-/m0/s1
Standard InChI Key: VOUFFAZMJOZZQT-ZDZUNBPVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 425.88 | Molecular Weight (Monoisotopic): 425.1255 | AlogP: 2.56 | #Rotatable Bonds: 8 |
Polar Surface Area: 108.47 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.65 | CX Basic pKa: 6.53 | CX LogP: 2.44 | CX LogD: 2.39 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.38 | Np Likeness Score: -1.15 |
1. Jin Y, Tan Z, He M, Tian B, Tang S, Hewlett I, Yang M.. (2010) SAR and molecular mechanism study of novel acylhydrazone compounds targeting HIV-1 CA., 18 (6): [PMID:20188575] [10.1016/j.bmc.2010.02.003] |
Source(1):